Celanese (CE) Projected to Post Quarterly Earnings on Monday

Celanese (NYSE:CE) is expected to be issuing its Q2 2025 quarterly earnings data after the market closes on Monday, August 11th. Analysts expect the company to announce earnings of $1.39 per share and revenue of $2.50 billion for the quarter.

Celanese Price Performance

CE stock opened at $47.96 on Friday. The firm has a market cap of $5.25 billion, a price-to-earnings ratio of -3.15, a PEG ratio of 1.83 and a beta of 1.10. The company has a quick ratio of 1.11, a current ratio of 1.94 and a debt-to-equity ratio of 2.20. Celanese has a 12-month low of $36.29 and a 12-month high of $142.54. The company’s fifty day simple moving average is $56.04 and its 200 day simple moving average is $54.80.

Celanese Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, August 11th. Investors of record on Tuesday, July 29th will be issued a $0.03 dividend. The ex-dividend date is Tuesday, July 29th. This represents a $0.12 annualized dividend and a yield of 0.3%. Celanese’s payout ratio is presently -0.79%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Royal Bank Of Canada reiterated a “sector perform” rating and set a $63.00 price objective (up previously from $53.00) on shares of Celanese in a report on Thursday, July 3rd. UBS Group upped their price objective on shares of Celanese from $51.00 to $66.00 and gave the company a “neutral” rating in a report on Wednesday, July 9th. BMO Capital Markets upgraded shares of Celanese from an “underperform” rating to a “market perform” rating and upped their price objective for the company from $46.00 to $55.00 in a report on Tuesday, May 20th. Mizuho upped their price objective on shares of Celanese from $50.00 to $59.00 and gave the company a “neutral” rating in a report on Tuesday, July 15th. Finally, Barclays upped their price objective on shares of Celanese from $59.00 to $62.00 and gave the company an “equal weight” rating in a report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, Celanese currently has a consensus rating of “Hold” and a consensus target price of $66.50.

Insider Activity at Celanese

In other news, SVP Mark Christopher Murray acquired 1,479 shares of Celanese stock in a transaction on Friday, May 23rd. The stock was acquired at an average cost of $52.18 per share, with a total value of $77,174.22. Following the transaction, the senior vice president owned 15,468 shares of the company’s stock, valued at approximately $807,120.24. This trade represents a 10.57% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.33% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Celanese

A hedge fund recently raised its stake in Celanese stock. NewEdge Advisors LLC raised its stake in Celanese Corporation (NYSE:CE) by 265.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,032 shares of the basic materials company’s stock after acquiring an additional 3,654 shares during the quarter. NewEdge Advisors LLC’s holdings in Celanese were worth $286,000 as of its most recent filing with the Securities & Exchange Commission. 98.87% of the stock is owned by hedge funds and other institutional investors.

About Celanese

Celanese Corporation, a chemical and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. It operates through Engineered Materials and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics.